Addex Therapeutics Ltd.
ADXN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574232
No open-market purchases or sales by Addex Therapeutics Ltd. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $274 in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Addex Therapeutics Ltd. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 5 | 4 | −1 |
| Shares | 377 | 199 | −178 (−47.2%) |
| Value | $3.46K | $1.85K | −$1.61K (−46.4%) |
New holders (1)
Institutions that held Addex Therapeutics Ltd. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 1 | $9 | 0.00% |
Sold out (2)
Institutions that held Addex Therapeutics Ltd. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Morgan Stanley | 100 | $941 |
| JPMorgan Chase & Co | 79 | $699 |